• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Obstetrics

No link between antenatal betamethasone and abnormal childhood bone development

byCordelia RossandMatthew Lin, MD
April 7, 2017
in Obstetrics, Pediatrics
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

There was no difference in bone mineral content, size and frequency of fractures in children who received repeated antenatal doses of glucocorticoids compared to those who received a single dose of glucocorticoids followed by repeat placebo doses.  

Evidence Rating: 1 (Excellent)

Study Rundown: Premature neonates are at increased risk of respiratory distress syndrome due to surfactant deficiency and poor lung development. While antenatal glucocorticoids are the standard of care in promoting fetal lung maturation in preterm neonates, glucocorticoids may also play a role in accelerated bone loss. In the Australian Collaborative Trial of Repeat Doses of Corticosteroids (ACTORDS), researchers investigated whether repeated doses of antenatal corticosteroids altered bone mass, size and mineralization in school-aged children compared to those exposed to a single dose of antenatal corticosteroids followed by repeat doses of placebo. Their data demonstrated no significant differences in bone mass size or mineralization between groups. Additionally, there were no significant differences between groups for body segment proportions, spinal mineral content/area and fracture incidence. Children who received repeated doses of antenatal corticosteroids did, however, have a significant clinical reduction in markers of RDS. This study is limited by the use of completed whole-body dual-energy radiograph absorptiometry (DXA), which primarily reflects changes in cortical rather than trabecular bone. Additionally, no radiologic evidence of fractures was obtained for analysis of secondary outcomes. Overall, this study provides reassurance to providers who chose to administer repeated doses of antenatal corticosteroids to reduce symptoms of RDS.

Click to read the study, published today in Pediatrics

Relevant Reading: Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth.

Study Author, Dr. Chris McKinlay, PhD, talks to 2 Minute Medicine: Liggins Institute and Department of Paediatrics: Child and Youth Health, University of Auckland, Auckland, New Zealand.

“Repeat doses of antenatal glucocorticoids for preterm birth reduce neonatal morbidity but uptake of this treatment has been limited by concern about long-term adverse effects, including on skeletal development. In this randomised trial, exposure to repeat doses of antenatal betamethasone compared with a single course of antenatal glucocorticoids did not alter bone mass at 6 to 8 years’ corrected age, and is unlikely to increase the risk of later osteoporosis in offspring.”

RELATED REPORTS

Global mortality of neonates born preterm has decreased nearly 50 percent since 1990

#VisualAbstract: Oral methylprednisolone may reduce risk of progressive renal failure in patients with IgA nephropathy: TESTING Trial

Oral methylprednisolone may reduce risk of progressive renal failure in patients with IgA nephropathy: TESTING Trial

In-Depth [randomized controlled trial]: In the original ACTORDS trial, pregnant women (N=982, 1146 live fetuses) with single to triplet pregnancy who had previously received antenatal glucocorticoids for ≥7 days and who were at risk of preterm delivery were randomized to receive further weekly treatments of either antenatal glucocorticoids or saline placebo if at continued risk of preterm delivery and <32 weeks’ gestation. The original study showed that infants exposed to repeat betamethasone compared to placebo had significant reductions in RDS. In this follow-up study, of 308 children were recruited, 185 completed DXA scans at 6-8 years corrected age. 91 were randomized to repeat antenatal betamethasone and 94 to placebo. The primary outcome was whole-body bone mineral content and area, while secondary outcomes included body segment proportions, spinal mineral content/area and fracture incidence. There were no significant differences in bone mineral content between repeat betamethasaone (median=553g; IQR=422-712) and placebo (median=567g; IQR=447-750) groups (geometric mean ratio=0.99; 95%CI=0.94-1.03, P=0.55). Additionally, there were no significant differences in secondary outcomes. In the repeat betamethasone and placebo groups, 12 (13%) and 10 (11%) of children experienced fractures (P=0.65).

Image: CC

©2017 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: bone healthfracture pediatricsintrapartum steroidsneonatologysteroids
Previous Post

Multiple myeloma management with lenalidomide, bortezomib and dexamethasone associated with prolonged progression-free survival

Next Post

Weight fluctuations associated with mortality in patients with coronary artery disease

RelatedReports

Increasing C-section room temperature linked to reduced neonatal, maternal hypothermia
Chronic Disease

Global mortality of neonates born preterm has decreased nearly 50 percent since 1990

June 15, 2022
#VisualAbstract: Oral methylprednisolone may reduce risk of progressive renal failure in patients with IgA nephropathy: TESTING Trial
StudyGraphics

#VisualAbstract: Oral methylprednisolone may reduce risk of progressive renal failure in patients with IgA nephropathy: TESTING Trial

June 2, 2022
Caplacizumab may induce faster resolution of a thrombotic thrombocytopenic purpura episode
Nephrology

Oral methylprednisolone may reduce risk of progressive renal failure in patients with IgA nephropathy: TESTING Trial

May 18, 2022
No decrease in infant mortality with maternal micronutrient supplementation in Bangladesh
Pediatrics

Noninvasive ventilation with neurally adjusted ventilatory assist (NIV-NAVA) outperforms nasal continuous positive airway pressure (NCPAP) post-extubation in preterm infants

May 6, 2022
Next Post
Long-term outcomes for off-pump and on-pump CABG are similar

Weight fluctuations associated with mortality in patients with coronary artery disease

Long term phototherapy can enhance treatment response in vitiligo

Long term phototherapy can enhance treatment response in vitiligo

Cerebral protection device effective in patients undergoing transcatheter aortic valve implantation

Transcatheter aortic valve replacement noninferior to surgery for intermediate-risk patients: The SURTAVI trial

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Early initiation of poststernotomy cardiac rehabilitation exercise training is effective and safe
  • 2 Minute Medicine Rewind July 4, 2022
  • Stereotactic body radiotherapy as a state of the art treatment option in inoperable non-small cell lung cancer [Classics Series]
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.